Concept: Streptomyces antibiotics as secondary metabolites

Streptomyces species are classic producers of secondary metabolites, including many clinically important antibiotics. These secondary metabolites are usually synthesized when growth slows, commonly beginning in late exponential phase and peaking around the stationary phase, often under nutrient limitation and high cell density. Thus, in a batch culture, the expected trends are: nutrient concentration decreases continuously, biomass increases and then plateaus, and antibiotic concentration rises after biomass has grown substantially and then remains high or plateaus rather than rapidly declining.

Why option (3) is correct

In option (3), the nutrient curve starts high and drops steadily toward low levels over time, which fits progressive substrate consumption in batch culture. The biomass curve (dashed) shows a sigmoidal increase that levels off, representing lag, exponential and stationary phases of Streptomyces growth. The antibiotic curve starts near zero, increases after some growth has occurred, and reaches a plateau while biomass has already approached its maximum, matching secondary metabolite production that begins in late log phase and remains roughly constant through stationary phase.

Why option (1) is incorrect

In option (1), nutrient concentration decreases, which is reasonable, but the antibiotic curve rises early and then declines sharply even while biomass is still relatively high, implying rapid antibiotic degradation or consumption. In most Streptomyces cultures, antibiotic levels tend to remain stable or decline only slowly once produced, because they are secreted secondary metabolites that often persist in the medium throughout stationary phase. Therefore, the pronounced late drop in antibiotic concentration in this curve is not typical for Streptomyces antibiotic production.

Why option (2) is incorrect

Option (2) shows nutrient levels high initially but then falling steeply, while biomass rises sharply and then declines strongly after reaching a peak. The antibiotic curve, however, peaks when biomass is already decreasing, suggesting that maximum antibiotic production occurs when the culture is entering death phase, which is not the general pattern reported for Streptomyces, where maximal antibiotic synthesis usually occurs in late exponential or early stationary phase with biomass still near its maximum and relatively stable. The strong decline in biomass and the timing of antibiotic peak therefore make this curve an inaccurate representation.

Why option (4) is incorrect

In option (4), nutrient concentration decreases as expected, but both biomass and antibiotic curves rise in almost parallel fashion and plateau at similar times, implying that antibiotic production is tightly growth‑associated rather than secondary. For Streptomyces, antibiotic biosynthesis is generally decoupled from rapid biomass increase and instead triggered by nutrient limitation, regulatory signals and entry into stationary phase, representing non‑growth‑associated or partially growth‑associated secondary metabolism. Because option (4) lacks the characteristic delay between biomass increase and antibiotic accumulation, it does not correctly depict Streptomyces antibiotic production.

SEO‑oriented introduction (for article use)

Antibiotic production by Streptomyces species is a classic example of secondary metabolism, where bioactive compounds accumulate mainly in late logarithmic and stationary phases rather than during rapid growth. Recognizing the correct antibiotic production by Streptomyces curve helps students visualize how nutrient depletion, biomass growth and secondary metabolite synthesis are linked in batch fermentation, and is frequently tested in bioprocess and microbiology exams.